GOLDMAN SACHS GROUP INC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 55 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 1.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$296,423
-86.8%
114,009
-78.3%
0.00%
Q1 2024$2,242,558
+3540.0%
526,422
+1626.0%
0.00%
Q4 2023$61,608
-34.7%
30,499
-46.6%
0.00%
Q2 2023$94,296
+294575.0%
57,149
+106.3%
0.00%
Q3 2022$32
+255.6%
27,704
+95.7%
0.00%
Q2 2022$9
-100.0%
14,159
-70.7%
0.00%
Q1 2022$126,000
-43.5%
48,312
-15.7%
0.00%
Q4 2021$223,000
-30.1%
57,307
-21.7%
0.00%
Q3 2021$319,000
+18.1%
73,165
+7.5%
0.00%
Q2 2021$270,000
+11.1%
68,030
+45.3%
0.00%
Q1 2021$243,000
-11.3%
46,826
-8.5%
0.00%
Q4 2020$274,000
-29.7%
51,167
-36.3%
0.00%
Q3 2020$390,000
+306.2%
80,327
+304.6%
0.00%
Q2 2020$96,000
-65.8%
19,851
-58.9%
0.00%
Q4 2019$281,000
+778.1%
48,336
+373.5%
0.00%
Q3 2019$32,000
-88.5%
10,209
-74.6%
0.00%
Q1 2019$278,000
+110.6%
40,160
+92.2%
0.00%
Q4 2018$132,000
-64.9%
20,895
-2.6%
0.00%
Q3 2018$376,00021,4540.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$42,776,000100.00%
Latash Investments, LLC 243,134$1,060,0000.66%
Bracebridge Capital, LLC 428,571$1,869,0000.16%
GSA CAPITAL PARTNERS LLP 297,229$1,296,0000.13%
PDT Partners, LLC 76,100$332,0000.02%
Jump Financial, LLC 49,700$216,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$798,0000.02%
IndexIQ Advisors LLC 86,461$377,0000.01%
Financial Advocates Investment Management 17,000$74,0000.01%
Brandywine Global Investment Management, LLC 125,016$545,0000.00%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders